Drug: betamethasone Quarter: 2016Q3
Total Records: 108 Number of Pages: 6
| DRUGNAME | PT | EventCount |
|---|---|---|
| BETAMETHASONE. | Myopathy | 3 |
| BETAMETHASONE. | Pancreatic carcinoma | 3 |
| BETAMETHASONE. | Pancreatic neoplasm | 3 |
| BETAMETHASONE BENZOATE | Toxic anterior segment syndrome | 2 |
| BETAMETHASONE DIPROPIONATE. | Drug ineffective | 2 |
| BETAMETHASONE DIPROPIONATE. | Drug ineffective for unapproved indication | 2 |
| BETAMETHASONE DIPROPIONATE. | Exposure during pregnancy | 2 |
| BETAMETHASONE DIPROPIONATE. | Foetal exposure during pregnancy | 2 |
| BETAMETHASONE DIPROPIONATE. | Glaucoma | 2 |
| BETAMETHASONE DIPROPIONATE. | Low birth weight baby | 2 |
| BETAMETHASONE DIPROPIONATE. | Premature baby | 2 |
| BETAMETHASONE DIPROPIONATE. | Sepsis neonatal | 2 |
| Betamethasone Sodium Phos/Betamethasone Acetate Inj Susp, USP (40042-0 | Exposure during pregnancy | 2 |
| Betamethasone Sodium Phos/Betamethasone Acetate Inj Susp, USP (40042-0 | Incorrect route of drug administration | 2 |
| Betamethasone Sodium Phos/Betamethasone Acetate Inj Susp, USP (40042-0 | No adverse event | 2 |
| BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE INJ SUSP, USP | Burning sensation | 2 |
| BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE INJ SUSP, USP | Exposure during pregnancy | 2 |
| BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE INJ SUSP, USP | Rash erythematous | 2 |
| Betamethasone, Dexchlorpheniramine | Erythema multiforme | 2 |
| Betamethasone, Dexchlorpheniramine | Pneumocystis jirovecii pneumonia | 2 |
Total Records: 108 Number of Pages: 6